Jan. 17 at 12:56 PM
$BEAT best scenario: a medical device company buys them out.
Second best: manufacturing relationship with cost projection per unit and advertising campaign with cost projections and this thing gets moving.
Worst case scenario: they dilute: SP goes sub dollar and the board takes a long vacation.
The R&D is done. They have manufacturing relationship. They already built the damn thing.
As I said before, they could take this thing to Omron or the like and have this available in every CVS in 6 months.
If you got in this thing under a dollar, you should have sold a long time ago and never looked back.
This has a 90% chance it’s a looser. Much lower risk opportunity out there.
Recommend: cut your losses and run.